Aurora Cannabis (NASDAQ:ACB – Get Free Report) will likely be releasing its earnings data before the market opens on Wednesday, February 5th. Analysts expect Aurora Cannabis to post earnings of ($0.09) per share and revenue of $80.01 million for the quarter. Persons that are interested in participating in the company’s earnings conference call can do so using this link.
Aurora Cannabis Trading Up 0.8 %
NASDAQ ACB opened at $3.75 on Wednesday. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.83 and a quick ratio of 1.88. The firm’s fifty day moving average price is $4.26 and its 200 day moving average price is $5.24. The company has a market capitalization of $205.73 million, a price-to-earnings ratio of -4.93 and a beta of 1.86. Aurora Cannabis has a 12 month low of $2.84 and a 12 month high of $9.35.
Wall Street Analyst Weigh In
A number of research firms recently commented on ACB. TD Securities raised shares of Aurora Cannabis to a “strong-buy” rating in a research report on Thursday, December 12th. TD Cowen began coverage on shares of Aurora Cannabis in a research report on Wednesday, December 11th. They issued a “buy” rating on the stock.
Aurora Cannabis Company Profile
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Recommended Stories
- Five stocks we like better than Aurora Cannabis
- Top Stocks Investing in 5G Technology
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- 10 Best Airline Stocks to Buy
- What Does the Future Hold for Eli Lilly?
- Airline Stocks – Top Airline Stocks to Buy Now
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.